Drugs News and Research

RSS

Family CV history indicates intensive treatment need for hypertensive patients

A family history of premature cardiovascular disease is a marker of increased mortality risk in patients with hypertension, report researchers.

10 Mar 2014

Majority of Latinas unaware of diabetes risk

Approximately 5.5 million Latinas suffer from elevated fasting plasma glucose (FPG) and nearly 4 million of those women were never told by a healthcare provider they were at risk for diabetes, pre-diabetes, or were borderline for diabetes.

10 Mar 2014

Harvard Review of Psychiatry provides updates on ASD research

Recent years have seen exciting progress in key areas of research on autism spectrum disorders (ASD): from possible genetic causes, to effective treatments for common symptoms and clinical problems, to promoting success for young people with ASD entering college. Updates on these and other advances in ASD research are presented in the March special issue of Harvard Review of Psychiatry.

10 Mar 2014

Study examines impact of the elimination of preferred pharmacy networks on Medicare Part D program

A new actuarial study released by The Pharmaceutical Care Management Association examining the impact proposed changes to the Medicare prescription drug program finds that eliminating preferred pharmacy networks in Part D would increase premiums by approximately $63 annually for over 75 percent of Part D enrollees and raise overall program costs by an estimated $24 billion over the next ten years.

10 Mar 2014

Regado receives Fast Track designation from FDA for REG1

Regado Biosciences, Inc., a biopharmaceutical company focused on the development of actively controllable therapeutics, today announced that the United States Food and Drug Administration has designated REG1 for anticoagulant therapy to be used in patients with coronary artery disease during percutaneous coronary interventions (PCI) as a Fast Track development program.

10 Mar 2014

BerGenBio receives grant to study novel therapeutics for inhibiting epithelial-mesenchymal transition

BerGenBio AS, an oncology biopharmaceutical company, is pleased to announce the award of a NOK 13 million grant from the Research Council of Norway's User-driven Research based Innovation programme (BIA) to help fund research into novel therapeutics for inhibiting tumor epithelial-mesenchymal transition (EMT), a key driver of metastasis (cancer spread) and a mechanism of drug-resistance.

10 Mar 2014

Study gives insights into designing new drugs to fight infections

Efforts to combat bacteria’s growing resistance to antibiotics could be helped by a key discovery about the complex processes that enable bugs to thrive.

10 Mar 2014

First Edition: March 10, 2014

Today's headlines include reports about how the Virginia Assembly's impasse on Medicaid expansion is playing out.

10 Mar 2014

Tubulin protein is a well-validated cancer drug target

Tubulin, the building-block protein of cellular microtubules, is a well-validated cancer drug target: Disrupting tubulin polymerization affects cytoskeletal function and thus cell division.

10 Mar 2014

UK waiting times for RA and PsA patients: an interview with Dr Marwan Bukhari, Consultant Rheumatologist at the University Hospitals of Morecambe Bay NHS Foundation Trust

Research shows that in cases of inflammatory joint disease, the earlier you catch the disease and suppress the immune system, the less likely a patient is to develop damaging and ongoing, chronic inflammation.

10 Mar 2014

Fibrotech successfully completes Phase Ia trial of anti-fibrotic compound FT011

Fibrotech, an Australian biopharmaceutical company developing a new class of drugs to prevent a massive health burden associated with fibrosis, today announced that its lead anti-fibrotic compound FT011 has successfully completed a Phase Ia trial in healthy volunteers demonstrating safety and tolerability up to doses of 1000mg.

10 Mar 2014

Longer looks: Health care in jail; preventing Medicare drug fraud; new medical codes

"Sheriff Ashe," [the waitress] began. "My daughter is in your jail." She then told me her daughter's story. "Laura," as I'll call her here, was a bright and sociable girl who, after graduating from high school, went on to community college.

10 Mar 2014

Researchers seek to understand causes of premature birth with support from March of Dimes

Five researchers seeking to understand the causes of premature birth with the goal of identifying women at risk of preterm labor and developing new treatments to prevent it have been awarded grant support from the March of Dimes.

10 Mar 2014

Findings provide new target for development of novel therapies to manage chronic pain

Scientists have shown for the first time that the abnormalities in the way the brain experiences pain may be to blame for the chronic pain suffered by osteoarthritis patients.

10 Mar 2014

Researchers develop new technique to map interactions between proteins at heart of many diseases

Researchers at the UNC School of Medicine have devised a new biochemical technique that will allow them and other scientists to delve much deeper than ever before into the specific cellular circuitry that keeps us healthy or causes disease.

10 Mar 2014

Florida could be bellwether state for Obamacare election strategies

Both parties are trying out messages in Tuesday's special election for a House seat. And Charlie Crist, former governor who is running again, is also in the news.

10 Mar 2014

Biomarkers for bone resorption predict outcomes for men with prostate cancer

Biomarkers for bone formation and resorption predict outcomes for men with castration-resistant prostate cancer, a team of researchers from UC Davis and their collaborators have found.

10 Mar 2014

Inherited Alzheimer's neuronal damage begins 10 to 20 years before symptoms appear

In a paper published in the prestigious journal Science Translational Medicine, Professor Colin Masters from the Florey Institute of Neuroscience and Mental Health and University of Melbourne - and colleagues in the UK and US - have found rapid neuronal damage begins 10 to 20 years before symptoms appear.

10 Mar 2014

Edison Pharmaceuticals initiates Phase 2B/3 study of EPI-743 in children with Leigh syndrome

Edison Pharmaceuticals today announced the initiation of a phase 2B/3 study entitled, "A Phase 2B/3 Open-label Study of EPI-743 in Children with Leigh Syndrome" to be conducted in conjunction with Dainippon Sumitomo Pharma Co, Ltd.

10 Mar 2014

Mutations in gene associated with leukaemia may affect growth, intellectual development in children

Mutations in a gene associated with leukaemia cause a newly described condition that affects growth and intellectual development in children, new research reports.

10 Mar 2014

Drugs News and Research

Family CV history indicates intensive treatment need for hypertensive patients

Majority of Latinas unaware of diabetes risk

Harvard Review of Psychiatry provides updates on ASD research

Study examines impact of the elimination of preferred pharmacy networks on Medicare Part D program

Regado receives Fast Track designation from FDA for REG1

BerGenBio receives grant to study novel therapeutics for inhibiting epithelial-mesenchymal transition

Study gives insights into designing new drugs to fight infections

First Edition: March 10, 2014

Tubulin protein is a well-validated cancer drug target

UK waiting times for RA and PsA patients: an interview with Dr Marwan Bukhari, Consultant Rheumatologist at the University Hospitals of Morecambe Bay NHS Foundation Trust

Fibrotech successfully completes Phase Ia trial of anti-fibrotic compound FT011

Longer looks: Health care in jail; preventing Medicare drug fraud; new medical codes

Researchers seek to understand causes of premature birth with support from March of Dimes

Findings provide new target for development of novel therapies to manage chronic pain

Researchers develop new technique to map interactions between proteins at heart of many diseases

Florida could be bellwether state for Obamacare election strategies

Biomarkers for bone resorption predict outcomes for men with prostate cancer

Inherited Alzheimer's neuronal damage begins 10 to 20 years before symptoms appear

Edison Pharmaceuticals initiates Phase 2B/3 study of EPI-743 in children with Leigh syndrome

Mutations in gene associated with leukaemia may affect growth, intellectual development in children

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News